ASP Isotopes Inc. (NASDAQ:ASPI) Director Robert John Andrew Ryan Acquires 4,313 Shares

ASP Isotopes Inc. (NASDAQ:ASPI) Director Robert John Andrew Ryan purchased 4,313 shares of the stock in a transaction that occurred on Monday, April 29th. The shares were bought at an average cost of $3.20 per share, for a total transaction of $13,801.60. Following the acquisition, the director now owns 555,868 shares of the company’s stock, valued at $1,778,777.60. The transaction was disclosed in a filing with the SEC, which is available through this link.

Robert John Andrew Ryan also recently made the following trade(s):

• On Thursday, April 25th, Robert John Andrew Ryan acquired 9,500 shares of ASP Isotopes stock. The shares were bought at an average cost of $3.42 per share, with a total value of $32,490.00.

ASP Isotopes Stock Performance

Shares of NASDAQ ASPI traded down $0.03 during trading on Wednesday, hitting $3.14. 142,881 shares of the company were exchanged, compared to its average volume of 581,597. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.85 and a quick ratio of 1.85. ASP Isotopes Inc. has a 1 year low of $0.28 and a 1 year high of $4.97. The firm’s fifty day moving average price is $3.72 and its 200 day moving average price is $2.53.

ASP Isotopes (NASDAQ:ASPI) last released its quarterly earnings data on Wednesday, April 10th. The company reported ($0.09) earnings per share for the quarter. The company had revenue of $0.43 million during the quarter. As a group, analysts anticipate that ASP Isotopes Inc. will post -0.11 EPS for the current year.

Analyst Ratings Changes

Separately, HC Wainwright lifted their target price on ASP Isotopes from $5.25 to $5.50 and gave the company a “buy” rating in a research note on Wednesday, April 17th.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in ASP Isotopes stock. HTLF Bank bought a new stake in ASP Isotopes Inc. (NASDAQ:ASPI) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 78,538 shares of the company’s stock, valued at approximately $141,000. HTLF Bank owned approximately 0.16% of ASP Isotopes as of its most recent filing with the Securities and Exchange Commission. 16.80% of the stock is currently owned by hedge funds and other institutional investors.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.